Anavex Life Sciences Corp (AVXL)

[Rubyred77]

He literally PR the P3 pediatric Rett trial didn’t meet its primary endpoint in a timely manner. Of course, that doesn’t fit the narrative though of Always.

Then there’s this:

ANAVEX®2-73 (BLARCAMESINE) PHASE 2B/3 STUDY MET PRIMARY AND KEY SECONDARY ENDPOINTS:

Robust, Statistically Significant and Clinically Meaningful Absolute Improvement in Cognitive Function as Measured by ADAS-Cog and ADCS-ADL